Ética

Public Health pharmacogenomics and the design principles for global public goods

Commercial opportunities and ethical pitfalls in personalized medicine- a myriad of reasons to

Genetics and cardiovascular disease- a policy statement from the American Heart Association

Regulatory Aspects of pharmacogenomics in clinical drug development

Multigenic control of drug response and regulatory decision-making in pharmacogenomics

Rhetoric and hype - where is the ethics in pharmacogenomics

Ethical perspectives on pharmacogenomic profiling in the drug development process

Ethical issues in developing pharmacogentic research partnershipcs American Indigenous communities

The ethics of CYP2D6 testing for patients considering tamoxifen

Facilitating clinical implementation of pharmacogenomics

Practical ethics-establishing a pathway to benefits for complex pharmacogenomic tests

Racializing drug desing-implications of pharmacogenomics for health disparities

Racing forward-the genomics and personalized medicine act

Challenges and pitfalls in the introduction of pharmacogenetics for cancer

Elements of informed consent for pharmacogenetic research-perspectives of the PWG

Genomics health care and society

Regresar al Acervo